Glenmark Pharmaceuticals gets USFDA nod for hypertension drug
The approved products is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Micardis HCT tablets.The company's current portfolio consists of 150 products authorised for distribution at the US marketplace and 52 ANDAs